Search results
Potential link found between Merck antiviral and mutated COVID strains
KREX articles via Yahoo News· 7 months agoMolnupiravir, known commercially as Lagevrio, is one of two COVID-19 antivirals authorized for...
Antiviral Covid drug linked to virus mutations, study suggests
Press Association News via AOL· 7 months agoAn antiviral drug used to treat Covid-19 patients could be linked to mutations in the virus, new...
Merck's COVID pill does not cut hospitalisation, death rates in many vaccinated adults - study
Reuters via Yahoo News· 1 year agoMerck & Co Inc's COVID antiviral molnupiravir speeds up recovery but does not reduce the...
Merck fourth quarter tops expectations on strong COVID pill sales
Reuters via Yahoo Finance· 1 year agoMerck & Co on Thursday reported higher-than-expected fourth-quarter earnings on strong sales of its...
Molnupiravir vs. Paxlovid: Which Is Better for COVID-19?
Verywell Health via Yahoo News· 11 months agoLagevrio (molnupiravir) and Paxlovid (nirmatrelvir and ritonavir) are prescription medications used...
A One-Shot COVID-19 Treatment Shows Promise
Time via Yahoo News· 1 year agoCredit - Yiu Yu Hoi—Getty Images The current medicine chest for treating COVID-19 is fairly sparse. Only one drug—remdesivir—is approved by the U.S. Food...
At All-Time Highs, Merck's Stock Is Nearing a Cliff
GuruFocus.com via Yahoo Finance· 1 year agoThroughout the beginning of the Covid-19 pandemic, pharmaceutical companies were mostly focused on the availability and effectiveness of vaccines....
Merck, Ridgeback Announce New Molnupiravir Data From Late-Stage COVID-19 Study
Benzinga via Yahoo Finance· 2 years agoMerck & Co Inc (NYSE: MRK) and Ridgeback Biotherapeutics announced that the Annals of Internal...
Pfizer, Merck trim prices in China for Paxlovid, molnupiravir - reports
Reuters via Yahoo Finance· 1 year agoPfizer and Merck have slightly lowered the prices of their respective Paxlovid and molnupiravir...
Merck sees sharp decline in COVID sales for 2023 after strong fourth quarter
Reuters via Yahoo Finance· 1 year agoMerck & Co on Thursday forecast 2023 earnings below Wall Street estimates along with an expected...